Related Experiment Video
Updated: May 8, 2026

Rapid Isolation of Dorsal Root Ganglion Macrophages
Published on: September 7, 2019
The known knowns of microglia-neuronal signalling in neuropathic pain
Simon Beggs1, Michael W Salter
1Program in Neurosciences & Mental Health, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
Abstract:
Microglia are key cellular mediators of plasticity in the spinal cord that drives the development and maintenance of pain hypersensitivity following peripheral nerve damage. An essential reactive microglial phenotype is characterized by induced expression of purinergic P2X4 receptors. Activation of these receptors initiates a core microglial-neuronal signalling pathway which through disinhibition transforms the output of dorsal horn neurons projecting to the brain pain networks. Here we describe recent advances in elucidating molecules that regulate key aspects of this core pathway, and opportunities for targeting critical signalling hubs to treat neuropathic pain.
Insights
Reactive microglia in the spinal cord drive neuropathic pain via P2X4 receptors. Targeting these pathways offers new strategies for treating pain hypersensitivity after nerve damage.
Area of Science:
- Neuroscience
- Immunology
- Pain Research
Background:
- Microglia are crucial for spinal cord plasticity, contributing to pain hypersensitivity after peripheral nerve injury.
- A specific reactive microglial phenotype involves increased expression of purinergic P2X4 receptors.
Purpose of the Study:
- To review recent advancements in understanding molecules that regulate the microglial-neuronal signaling pathway.
- To identify opportunities for therapeutic targeting of key signaling hubs in neuropathic pain.
Main Methods:
- Literature review of recent research on microglial function in neuropathic pain.
- Analysis of signaling pathways involving purinergic P2X4 receptors and neuronal disinhibition.
Main Results:
- Purinergic P2X4 receptor activation in microglia initiates a signaling cascade.
- This cascade leads to disinhibition of dorsal horn neurons, altering pain signal transmission to the brain.
Conclusions:
- Microglia-derived purinergic signaling is central to neuropathic pain mechanisms.
- Targeting specific molecules within this pathway presents potential therapeutic avenues for treating neuropathic pain.
Related Concept Videos
Nociception
Analgesia and Pain Management
Opioid Receptors: Overview
Pain
